186 related articles for article (PubMed ID: 22959474)
1. Characteristics and outcomes of patients with Ewing sarcoma over 40 years of age at diagnosis.
Karski EE; Matthay KK; Neuhaus JM; Goldsby RE; Dubois SG
Cancer Epidemiol; 2013 Feb; 37(1):29-33. PubMed ID: 22959474
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes in patients with secondary Ewing sarcoma.
Applebaum MA; Goldsby R; Neuhaus J; DuBois SG
Pediatr Blood Cancer; 2013 Apr; 60(4):611-5. PubMed ID: 22847990
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
4. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study.
Shi J; Yang J; Ma X; Wang X
J Orthop Surg Res; 2020 Mar; 15(1):88. PubMed ID: 32131863
[TBL] [Abstract][Full Text] [Related]
6. Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.
Worch J; Ranft A; DuBois SG; Paulussen M; Juergens H; Dirksen U
Pediatr Blood Cancer; 2018 Sep; 65(9):e27251. PubMed ID: 29856530
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma.
Applebaum MA; Worch J; Matthay KK; Goldsby R; Neuhaus J; West DC; Dubois SG
Cancer; 2011 Jul; 117(13):3027-32. PubMed ID: 21692057
[TBL] [Abstract][Full Text] [Related]
8. Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis.
Martin E; Senders JT; Ter Wengel PV; Smith TR; Broekman MLD
Acta Neurochir (Wien); 2019 Feb; 161(2):317-325. PubMed ID: 30578430
[TBL] [Abstract][Full Text] [Related]
9. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
10. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.
Davenport JR; Vo KT; Goldsby R; West DC; DuBois SG
Pediatr Blood Cancer; 2016 Jun; 63(6):1091-5. PubMed ID: 26891183
[TBL] [Abstract][Full Text] [Related]
11. Ewing Sarcoma of the Head and Neck.
Ellis MA; Gerry DR; Neskey DM; Lentsch EJ
Ann Otol Rhinol Laryngol; 2017 Mar; 126(3):179-184. PubMed ID: 28056517
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
Wong T; Goldsby RE; Wustrack R; Cash T; Isakoff MS; DuBois SG
Pediatr Blood Cancer; 2015 Nov; 62(11):1947-51. PubMed ID: 26173989
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.
Applebaum MA; Goldsby R; Neuhaus J; DuBois SG
Pediatr Blood Cancer; 2012 Oct; 59(4):617-20. PubMed ID: 22184129
[TBL] [Abstract][Full Text] [Related]
14. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005.
Jawad MU; Cheung MC; Min ES; Schneiderbauer MM; Koniaris LG; Scully SP
Cancer; 2009 Aug; 115(15):3526-36. PubMed ID: 19548262
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of local treatment strategies in non-metastatic Ewing sarcoma of bone.
Zhang WT; Zhang WW; He ZY; Sun JY; Zhang L; Xia Q; Wu SG
Expert Rev Anticancer Ther; 2018 May; 18(5):501-506. PubMed ID: 29537323
[TBL] [Abstract][Full Text] [Related]
18. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
19. Disparities in incidence and survival for patients with Ewing sarcoma in Florida.
Dhir A; Rahul R; Liu Q; Pham D; Kronenfeld R; Koru-Sengul T; Pinheiro PS
Cancer Med; 2024 Apr; 13(8):e7151. PubMed ID: 38650521
[TBL] [Abstract][Full Text] [Related]
20. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]